ANTIVA BIOSCIENCES, INC.

Profile

Company Names

ANTIVA BIOSCIENCES, INC.
HERA THERAPEUTICS INC.

Addresses

555 TWIN DOLPHIN DRIVE, SUITE 620, REDWOOD CITY, CA 94065

280 OLD COUNTY ROAD #257, BRISBANE, CA 94005

6000 SHORELINE COURT, SUITE 203, SOUTH SAN FRANCISCO, CA 94080

3210 MERRYFIELD ROW, SAN DIEGO, CA 92121

C/O JANSSEN LABORATORY ACCELERATOR, 3210 MERRYFIELD ROW, SAN DIEGO, CA 92121

14024 RUE SAINT RAPHAEL, DEL MAR, CA 92014

Phone Numbers

650-906-9229
(650) 822-1400
8583425556
858-342-5556
415 983 1000

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2012

State Incorporated:

DELAWARE

Total Amount Raised:

$96,794,613.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2023-04-24 
$38,535,985.00 
$52,999,990.00 
$14,464,005.00 
Equity 
7
2021-10-25 
$15,639,364.00 
$31,001,635.00 
$15,362,271.00 
Equity 
6
2018-07-06 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
5
2017-02-15 
$14,740,756.00 
$25,941,512.00 
$11,200,756.00 
Equity 
4
2015-05-27 
$8,907,483.00 
$15,969,973.00 
$7,062,490.00 
Equity 
3
2014-12-08 
$1,745,019.00 
$2,545,018.00 
$799,999.00 
Equity 
2
2014-06-24 
$1,100,000.00 
$1,300,000.00 
$200,000.00 
Debt 
1
2013-02-26 
$1,126,006.00 
$1,126,006.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KRISTINE 
 
BALL 
EXECUTIVE OFFICER, DIRECTOR
ANTIVA BIOSCIENCES, INC.
KEITH 
 
BLEY 
EXECUTIVE OFFICER
ANTIVA BIOSCIENCES, INC.
MICHAEL 
 
CANNON 
DIRECTOR
HUTCHINSON SENIOR CARE SERVICES   |  HUTCHINSON HEALTH CARE   |  HERA THERAPEUTICS INC.   |  SOLEXEL, INC.   |  LAV GEAR PARENT, INC.   |  EUREKA THERAPEUTICS INC   |  COMPLX, INC.   |  GLEASON TECHNOLOGY, INC.
MICHAEL 
D. 
CANNON 
DIRECTOR
HERA THERAPEUTICS INC.   |  ANTIVA BIOSCIENCES, INC.   |  EUREKA THERAPEUTICS, INC.
ELAINE 
 
CHIEN 
EXECUTIVE OFFICER
ANTIVA BIOSCIENCES, INC.
ORANEE 
 
DANIELS 
EXECUTIVE OFFICER
ANTIVA BIOSCIENCES, INC.
RAJU 
 
GADIRAJU 
EXECUTIVE OFFICER
ANTIVA BIOSCIENCES, INC.
RAJU 
 
GADIRAJU, PH.D. 
EXECUTIVE OFFICER
ANTIVA BIOSCIENCES, INC.
BRIAN 
 
GOODMAN 
DIRECTOR
ORNA THERAPEUTICS HOLDINGS, LLC   |  ANTIVA BIOSCIENCES, INC.
KARL 
Y 
HOSTETLER 
EXECUTIVE OFFICER, DIRECTOR
HERA THERAPEUTICS INC.
KARL 
Y. 
HOSTETLER 
EXECUTIVE OFFICER, DIRECTOR
HERA THERAPEUTICS INC.
WENDE 
 
HUTTON 
DIRECTOR
TRANSCEND MEDICAL INC   |  APIERON INC   |  CALIBRA MEDICAL, INC.   |  THERACLONE SCIENCES, INC.   |  REVISION OPTICS INC   |  ALTHEOS, INC.   |  ALDEA PHARMACEUTICALS, INC.   |  MATURE WOMEN-S HEALTH SOLUTIONS, INC.   |  DERMIRA, INC.   |  LABRYS BIOLOGICS, INC.   |  BUTTERFLY HEALTH, INC.   |  CHRONO THERAPEUTICS INC.   |  MINIMALLY INVASIVE DEVICES INC.   |  HERA THERAPEUTICS INC.   |  ONCORESPONSE INC   |  HYALEX ORTHOPAEDICS, INC.   |  QLARIS BIO, INC.   |  STARGAZER PHARMACEUTICALS, INC.   |  GLOOKO, INC.   |  ALCHERA INC   |  ANTIVA BIOSCIENCES, INC.   |  ONCORESPONSE, INC
WENDE 
S. 
HUTTON 
DIRECTOR
DERMIRA, INC.   |  ANTIVA BIOSCIENCES, INC.
WENDEE 
S. 
HUTTON 
DIRECTOR
ANTIVA BIOSCIENCES, INC.
STEVEN 
 
JAMES 
DIRECTOR
HERA THERAPEUTICS INC.   |  CHRONO THERAPEUTICS INC.   |  VENTUS THERAPEUTICS U.S., INC.   |  ANTIVA BIOSCIENCES, INC.   |  JUVENA THERAPEUTICS, INC.
STEVEN 
P. 
JAMES 
DIRECTOR
ARMETHEON, INC.   |  ANTIVA BIOSCIENCES, INC.   |  PIONYR IMMUNOTHERAPEUTICS, INC.
TING 
 
JIA 
DIRECTOR
ANTIVA BIOSCIENCES, INC.   |  OCTAGON INVESTMENTS FUND LP   |  OCTAGON INVESTMENTS OFFSHORE FUND LTD.   |  OCTAGON PRIVATE OPPORTUNITIES FUND LP   |  OCTAGON PRIVATE OPPORTUNITIES OFFSHORE FUND LP   |  OCTAGON SPECIAL OPPORTUNITIES FUND LP -- SERIES 1   |  OCTAGON SPECIAL OPPORTUNITIES FUND LP -- SERIES 2   |  OCTAGON SPECIAL OPPORTUNITIES FUND LP -- SERIES 3   |  NIKANG THERAPEUTICS, INC.   |  OCTAGON SPECIAL OPPORTUNITIES FUND LP -- SERIES 4   |  OCTAGON SPECIAL OPPORTUNITIES FUND LP -- SERIES WU   |  ANBIO THERAPEUTICS LTD.   |  BLUEJAY THERAPEUTICS, INC.   |  OCTAGON PRIVATE OPPORTUNITIES FUND II LP   |  OCTAGON PRIVATE OPPORTUNITIES OFFSHORE FUND II LP
DAVID 
 
KABAKOFF 
DIRECTOR
TRIUS THERAPEUTICS INC   |  ALLYLIX INC.   |  CEBIX INC   |  SOFINNOVA HEALTHQUEST PARTNERS, L.P.   |  LINEAGEN, INC   |  HERA THERAPEUTICS INC.   |  HEALTHQUEST PARTNERS II, L.P.   |  NEXTCURE, INC.   |  BIOTHERANOSTICS, INC.   |  DAUNTLESS 1, INC.   |  DAUNTLESS 2, INC.   |  ANTIVA BIOSCIENCES, INC.   |  BIOCLIN THERAPEUTICS, INC.   |  NEURANA PHARMACEUTICALS, INC.   |  RAINIER THERAPEUTICS, INC.   |  RARECYTE, INC.
DAVID 
 
KABAKOFF, PH.D. 
DIRECTOR
DAUNTLESS 1, INC.   |  CASTLE BIOSCIENCES INC   |  ANTIVA BIOSCIENCES, INC.
GAIL 
 
MADERIS 
EXECUTIVE OFFICER, DIRECTOR
TRINITY BIOSYSTEMS INC   |  NOVABAY PHARMACEUTICALS, INC.   |  ANTIVA BIOSCIENCES, INC.   |  VALITOR, INC.
VINZENZ 
 
PLOERER 
DIRECTOR
CLARASSANCE, INC.   |  THERABRON THERAPEUTICS, INC.   |  NAVITOR PHARMACEUTICALS, INC.   |  TYROGENEX, INC.   |  ANTIVA BIOSCIENCES, INC.   |  GENO LLC
WILLIAM 
 
RESPESS 
DIRECTOR
HERA THERAPEUTICS INC.
WILLIAM 
L. 
RESPESS 
DIRECTOR
HERA THERAPEUTICS INC.
BENI 
 
ROVINSKI 
DIRECTOR
ANTIVA BIOSCIENCES, INC.
BENJAMIN 
 
ROVINSKI 
DIRECTOR
AURINIA PHARMACEUTICALS INC.   |  VASCULAR PHARMACEUTICALS, INC.   |  ANTIVA BIOSCIENCES, INC.   |  ANTIOS THERAPEUTICS INC.
CLIFFORD 
 
SAMUEL 
DIRECTOR
ANTIVA BIOSCIENCES, INC.
JOHN 
 
SAYWARD 
EXECUTIVE OFFICER
HERA THERAPEUTICS INC.
JOHN 
W. 
SAYWARD 
EXECUTIVE OFFICER
HERA THERAPEUTICS INC.   |  DIGIRAD CORP
FLORENCIA 
 
SEGAL 
DIRECTOR
ANTIVA BIOSCIENCES, INC.
MICHAEL 
J 
SULLIVAN 
EXECUTIVE OFFICER
HERA THERAPEUTICS INC.
MICHAEL 
J. 
SULLIVAN 
EXECUTIVE OFFICER
DECORATI INC   |  ROOTMUSIC, INC.   |  OLD LINE BANCSHARES INC   |  PBWORKS INC.   |  HERA THERAPEUTICS INC.   |  BOREALIS STRATEGIC CAPITAL OFFSHORE FUND L.P.   |  BOREALIS STRATEGIC CAPITAL FUND L.P.
SARAH 
 
WALTER 
EXECUTIVE OFFICER
ANTIVA BIOSCIENCES, INC.
JENNY 
 
YIP 
DIRECTOR
ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND, L.P.   |  ADJUVANT GLOBAL HEALTH TECHNOLOGY FUND DE, L.P.   |  STACK DIAGNOSTICS, INC.   |  CHROMACODE, INC.   |  54GENE, INC.   |  ANTIVA BIOSCIENCES, INC.   |  EVOFEM BIOSCIENCES, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-10-11
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-04-24 
2023-05-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-04-24 
2021-11-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-10-25 
2018-07-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-06 
2017-08-28
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-15 
2017-04-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-02-15 
2015-06-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-05-27 
2014-12-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-08 
2014-07-10
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2014-06-24 
2013-09-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-26 
2013-03-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-02-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
N/A
NONE